U.S. Gold (USAU) Competitors

Opiant Pharmaceuticals (NASDAQ:OPNT) and U.S. Gold (NASDAQ:USAU) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, community ranking, risk and earnings.

Do analysts rate OPNT or USAU?

U.S. Gold has a consensus target price of $13.00, indicating a potential upside of 66.03%. Given U.S. Gold's stronger consensus rating and higher possible upside, analysts clearly believe U.S. Gold is more favorable than Opiant Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Opiant Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
U.S. Gold	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk and volatility, OPNT or USAU?

Opiant Pharmaceuticals has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, U.S. Gold has a beta of 1.45, suggesting that its share price is 45% more volatile than the S&P 500.

Is OPNT or USAU more profitable?

U.S. Gold has a net margin of 0.00% compared to Opiant Pharmaceuticals' net margin of -147.90%. U.S. Gold's return on equity of -42.74% beat Opiant Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Opiant Pharmaceuticals	-147.90%	-97.03%	-59.66%
U.S. Gold	N/A	-42.74%	-32.16%

Do institutionals & insiders hold more shares of OPNT or USAU?

42.4% of Opiant Pharmaceuticals shares are held by institutional investors. Comparatively, 6.6% of U.S. Gold shares are held by institutional investors. 25.2% of Opiant Pharmaceuticals shares are held by company insiders. Comparatively, 12.6% of U.S. Gold shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer OPNT or USAU?

Opiant Pharmaceuticals received 62 more outperform votes than U.S. Gold when rated by MarketBeat users. However, 70.14% of users gave U.S. Gold an outperform vote while only 64.23% of users gave Opiant Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Opiant Pharmaceuticals	Outperform Votes 264 64.23%	Underperform Votes 147 35.77%
U.S. Gold	Outperform Votes 202 70.14%	Underperform Votes 86 29.86%

Which has higher earnings & valuation, OPNT or USAU?

Opiant Pharmaceuticals has higher revenue and earnings than U.S. Gold. U.S. Gold is trading at a lower price-to-earnings ratio than Opiant Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Opiant Pharmaceuticals	$47.78M	0.00	$3.01M	-$6.56	N/A
U.S. Gold	N/A	N/A	-$6.90M	-$0.83	-9.43

Does the media prefer OPNT or USAU?

In the previous week, U.S. Gold had 14 more articles in the media than Opiant Pharmaceuticals. MarketBeat recorded 14 mentions for U.S. Gold and 0 mentions for Opiant Pharmaceuticals. U.S. Gold's average media sentiment score of 0.01 beat Opiant Pharmaceuticals' score of 0.00 indicating that U.S. Gold is being referred to more favorably in the news media.

Company	Overall Sentiment
Opiant Pharmaceuticals	Neutral
U.S. Gold	Neutral

Summary

U.S. Gold beats Opiant Pharmaceuticals on 11 of the 17 factors compared between the two stocks.